Drug, Meal and Formulation Interactions Influencing Drug Absorption After Oral Administration

Drug-drug, drug-formulation and drug-meal interactions are of clinical concern for orally administered drugs that possess a narrow therapeutic index. This review presents the current status of information regarding interactions which may influence the gastrointestinal (GI) absorption of orally administered drugs.Absorption interactions have been classified on the basis of rate-limiting processes. These processes are put in the context of drug and formulation physicochemical properties and oral input influences on variable GI physiology. Interaction categorisation makes use of a biopharmaceutical classification system based on drug aqueous solubility and membrane permeability and their contributions towards absorption variability. Overlaying this classification it is important to be aware of the effect that the magnitudes of drug dosage and volume of fluid administration can have on interactions involving a solubility rate limits.GI regional differences in membrane permeability are fundamental to the rational development of extended release dosage forms as well as to predicting interaction effects on absorption from immediate release dosage forms. The effect of meals on the regional-dependent intestinal elimination of drugs and their involvement in drug absorption interactions is also discussed. Although the clinical significance of such interactions is certainly dependent on the narrowness of the drug therapeutic index, clinical aspects of absorption delays and therapeutic failures resulting from various interactions are also important.

[1]  S. Lewis,et al.  Intestinal absorption of oestrogen: the effect of altering transit‐time , 1998, European journal of gastroenterology & hepatology.

[2]  C. Marchbanks Drug‐Drug Interactions With Fluoroquinolones , 1993, Pharmacotherapy.

[3]  L. Benet,et al.  Overlapping substrate specificities of cytochrome P450 3A and P-glycoprotein for a novel cysteine protease inhibitor. , 1998, Drug metabolism and disposition: the biological fate of chemicals.

[4]  C. Lieber Mechanisms of ethanol-drug-nutrition interactions. , 1994, Journal of toxicology. Clinical toxicology.

[5]  Lawrence X. Yu,et al.  Compartmental transit and dispersion model analysis of small intestinal transit flow in humans , 1996 .

[6]  D. Sadowski Drug Interactions with Antacids , 1994, Drug safety.

[7]  W. Heizer,et al.  Effect of Altering Small Bowel Transit Time on Sustained Release Theophylline Absorption , 1989, Journal of clinical pharmacology.

[8]  O. H. Chan,et al.  Discrimination between drug candidates using models for evaluation of intestinal absorption , 1997 .

[9]  J. Mucklow,et al.  Studies of the oral bioavailability of alendronate , 1995, Clinical pharmacology and therapeutics.

[10]  C. Lieber,et al.  Inhibition of drug metabolism by acute ethanol intoxication. A hepatic microsomal mechanism. , 1970, The American journal of medicine.

[11]  P. du Souich,et al.  Influence of food on the bioavailability of diltiazem and two of its metabolites following the administration of conventional tablets and slow-release capsules. , 1990, Biopharmaceutics & drug disposition.

[12]  J. Lin,et al.  pH-dependent oral absorption of L-735,524, a potent HIV protease inhibitor, in rats and dogs. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[13]  K. Ogawa,et al.  Gastrointestinal absorption of chlorothiazide: evaluation of a method using salicylazosulfapyridine and acetaminophen as the marker compounds for determination of the gastrointestinal transit time in the dog. , 1990, Chemical & pharmaceutical bulletin.

[14]  G. Garber,et al.  The effect of a protein meal on zidovudine pharmacokinetics in HIV-infected patients. , 1992, British journal of clinical pharmacology.

[15]  N. Mizuno,et al.  Effect of a high-fat meal on the bioavailability of phenytoin in a commercial powder with a large particle size. , 1993, International journal of clinical pharmacology, therapy, and toxicology.

[16]  J. R. Green,et al.  Pharmacokinetics of carbamazepine in normal man , 1975, Clinical pharmacology and therapeutics.

[17]  H. Liedholm,et al.  Concomitant food intake does enhance the bioavailability and effect of hydralazine , 1985, Clinical pharmacology and therapeutics.

[18]  W. Barron,et al.  Effect of food on the absorption of frusemide and bumetanide in man. , 2003, British journal of clinical pharmacology.

[19]  U. Fuhr Drug Interactions with Grapefruit Juice , 1998, Drug safety.

[20]  H. Schröder,et al.  Absorption, metabolism, and excretion of salicylazosulfapyridine in man , 1972, Clinical pharmacology and therapeutics.

[21]  A. Mclean,et al.  Reduction of first‐pass hepatic clearance of propranolol by food , 1981, Clinical pharmacology and therapeutics.

[22]  P. McNamara,et al.  Food, splanchnic blood flow, and bioavailability of drugs subject to first‐pass metabolism , 1978, Clinical pharmacology and therapeutics.

[23]  R. Helmreich,et al.  The importance of human factors in the operating room. , 1994, Anesthesiology.

[24]  J. Tillement,et al.  Systemic Antifungal Agents , 1998, Drug safety.

[25]  T. Schiano,et al.  Decreased intrinsic factor secretion in AIDS: relation to parietal cell acid secretory capacity and vitamin B12 malabsorption. , 1992, The American journal of gastroenterology.

[26]  R. Juhl,et al.  Decreased bioavailability of digoxin due to antacids and kaolin-pectin. , 1976, The New England journal of medicine.

[27]  J. Wagner,et al.  Influence of kaolin--pectin suspension on digoxin bioavailability. , 1978, Journal of pharmaceutical sciences.

[28]  H. Pan,et al.  Pharmacokinetics and pharmacodynamics of pravastatin alone and with cholestyramine in hypercholesterolemia , 1990, Clinical pharmacology and therapeutics.

[29]  D. Bagchi,et al.  Stress, diet and alcohol‐induced oxidative gastrointestinal mucosal injury in rats and protection by bismuth subsalicylate , 1998, Journal of applied toxicology : JAT.

[30]  S. Mochizuki,et al.  Influence of cisapride on the pharmacokinetics and antihypertensive effect of sustained-release nifedipine. , 1996, Internal medicine.

[31]  H. Liedholm,et al.  Concomitant food intake can increase the bioavailability of propranolol by transient inhibition of its presystemic primary conjugation , 1986, Clinical pharmacology and therapeutics.

[32]  Sievers Ml A study of achlorhydria among southwestern American Indians. , 1966 .

[33]  P. Gubbins,et al.  Drug Absorption in Gastrointestinal Disease and Surgery , 1991, Clinical pharmacokinetics.

[34]  H. Gin,et al.  The Influence of Guar Gum on Absorption of Metformin from the Gut in Healthy Volunteers , 1989, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[35]  K. Desante,et al.  Pharmacokinetic evaluation of a drug interaction between kaolin--pectin and clindamycin. , 1978, Journal of pharmaceutical sciences.

[36]  M. Kamm,et al.  The effect of an antacid and food on the absorption of cimetidine and ranitidine , 1990, The Journal of pharmacy and pharmacology.

[37]  H. Lode,et al.  Influence of ranitidine, pirenzepine, and aluminum magnesium hydroxide on the bioavailability of various antibiotics, including amoxicillin, cephalexin, doxycycline, and amoxicillin-clavulanic acid , 1989, Antimicrobial Agents and Chemotherapy.

[38]  C. le Grimellec,et al.  Increase in membrane fluidity modulates sodium-coupled uptakes and cyclic AMP synthesis by renal proximal tubular cells in primary culture. , 1990, Biochimica et biophysica acta.

[39]  K. Lawson,et al.  Olestra, a nonabsorbed, noncaloric replacement for dietary fat: a review. , 1997, Drug metabolism reviews.

[40]  J. Kisicki,et al.  Effect of Increasing Gastric pH with Famotidine on the Absorption and Oral Pharmacokinetics of the Inotropic Agent Vesnarinone , 1998, Journal of clinical pharmacology.

[41]  S. Bondesen,et al.  Kinetics of 5-aminosalicylic acid after jejunal instillation in man. , 1983, British journal of clinical pharmacology.

[42]  D. Fleisher,et al.  Influence of D-glucose-induced water absorption on rat jejunal uptake of two passively absorbed drugs. , 1992, Journal of pharmaceutical sciences.

[43]  J. Dressman,et al.  Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. , 1997, Journal of pharmaceutical sciences.

[44]  O. Keene,et al.  The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan. , 1991, European neurology.

[45]  C. Regårdh,et al.  Effects of grapefruit juice ingestion – pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men , 1997, European Journal of Clinical Pharmacology.

[46]  J. Meyer,et al.  Inhibition of gastric emptying by glucose depends on length of intestine exposed to nutrient. , 1989, The American journal of physiology.

[47]  G. Lensmeyer,et al.  Effect of a high-protein meal on gabapentin pharmacokinetics , 1996, Epilepsy Research.

[48]  D. B. Goldstein,et al.  The effects of drugs on membrane fluidity. , 1984, Annual review of pharmacology and toxicology.

[49]  J. Elashoff,et al.  Gastric emptying of solid food is most potently inhibited by carbohydrate in the canine distal ileum. , 1992, Gastroenterology.

[50]  A. Pearson,et al.  Intestinal permeability in Crohn's disease. , 1989, Archives of disease in childhood.

[51]  A. Zinsmeister,et al.  Relation between antral motility and gastric emptying of solids and liquids in humans. , 1985, The American journal of physiology.

[52]  E. Brendel,et al.  Carvedilol increases the systemic bioavailability of oral digoxin. , 1990, British journal of clinical pharmacology.

[53]  L Hendeles,et al.  Food-induced "dose-dumping" from a once-a-day theophylline product as a cause of theophylline toxicity. , 1985, Chest.

[54]  G. Amidon,et al.  Oral absorption of 21-corticosteroid esters: a function of aqueous stability and intestinal enzyme activity and distribution. , 1986, Journal of pharmaceutical sciences.

[55]  P. Gubbins,et al.  Drug Absorption in Gastrointestinal Disease and Surgery , 1989, Pharmacotherapy.

[56]  K. Brouwer,et al.  Physiologic pharmacokinetic modeling of gastrointestinal blood flow as a rate-limiting step in the oral absorption of digoxin: implications for patients with congestive heart failure receiving epoprostenol. , 1996, Journal of pharmaceutical sciences.

[57]  M. Fischl,et al.  Didanosine reduces atevirdine absorption in subjects with human immunodeficiency virus infections , 1996, Antimicrobial agents and chemotherapy.

[58]  P. Schwandt,et al.  Interaction between fibre and Iovastatin , 1991, The Lancet.

[59]  P. Welling Interactions Affecting Drug Absorption , 1984, Clinical pharmacokinetics.

[60]  L. Munck,et al.  Baclofen (β-p-chlorophenyl-γ-aminobutyric acid) transport across rat jejunum , 1993 .

[61]  V. Shah,et al.  Influence of dioctyl sodium sulfosuccinate on the absorption of tetracycline. , 1986, Biopharmaceutics & drug disposition.

[62]  J. Morley,et al.  Do calories, osmolality, or calcium determine gastric emptying? , 1985, The American journal of physiology.

[63]  L. Benet,et al.  Effect of Food on the Pharmacokinetics of Cyclosporine in Healthy Subjects Following Oral and Intravenous Administration , 1990, Journal of clinical pharmacology.

[64]  U. Fuhr,et al.  Ciprofloxacin absorption in different regions of the human gastrointestinal tract. Investigations with the hf-capsule. , 1990, British journal of clinical pharmacology.

[65]  J. A. Thomas,et al.  Interactions between drugs and nutrients. , 1996, Advances in pharmacology.

[66]  Peter B. Goldman Olestra: Assessing its potential to interact with drugs in the gastrointestinal tract , 1997, Clinical pharmacology and therapeutics.

[67]  P. Welling,et al.  Influence of food and fluid volume on chlorothiazide bioavailability: comparison of plasma and urinary excretion methods. , 1982, Journal of pharmaceutical sciences.

[68]  P. Sinko,et al.  Carrier‐mediated intestinal absorption of valacyclovir, the L‐valyl ester prodrug of acyclovir. 1. Interactions with peptides, organic anions and organic cations in rats , 1998, Biopharmaceutics & drug disposition.

[69]  G. Amidon,et al.  Noncompetitive inhibition of cephradine uptake by enalapril in rabbit intestinal brush-border membrane vesicles: an enalapril specific inhibitory binding site on the peptide carrier. , 1994, The Journal of pharmacology and experimental therapeutics.

[70]  J. Kuhlmann,et al.  Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin. , 1997, International journal of clinical pharmacology and therapeutics.

[71]  S. Broder,et al.  Pharmacokinetics of 2',3' ‐dideoxyinosine in patients with severe human immunodeficiency infection. II. The effects of different oral formulations and the presence of other medications , 1991, Clinical pharmacology and therapeutics.

[72]  J. Zhi,et al.  The Effect of Orlistat, an Inhibitor of Dietary Fat Absorption, on the Pharmacokinetics of β‐Carotene in Healthy Volunteers , 1996, Journal of clinical pharmacology.

[73]  F. Merkus,et al.  New insights into the pharmacokinetics of spironolactone , 1985, Clinical pharmacology and therapeutics.

[74]  G. Amidon,et al.  Peptide-based Drug Design, Controlling Transport and Metabolism , 1995 .

[75]  A. Li,et al.  Preclinical evaluation of drug-drug interaction potential: present status of the application of primary human hepatocytes in the evaluation of cytochrome P450 induction. , 1997, Chemico-biological interactions.

[76]  P. Tothill,et al.  EFFECT OF GEL FIBRE ON GASTRIC EMPTYING AND ABSORPTION OF GLUCOSE AND PARACETAMOL , 1979, The Lancet.

[77]  D. Rowbotham,et al.  Pharmacokinetic Drug Interactions with Gastrointestinal Motility Modifying Agents , 1994, Clinical pharmacokinetics.

[78]  R. Jandacek The effect of nonabsorbable lipids on the intestinal absorption of lipophiles. , 1982, Drug metabolism reviews.

[79]  R. Unger,et al.  Evidence for a role of splanchnic somatostatin in the homeostasis of ingested nutrients. , 1979, Endocrinology.

[80]  T. Chaudhuri,et al.  Update: pharmaceuticals and gastric emptying. , 1990, The American journal of gastroenterology.

[81]  D. Giesing,et al.  Effect of food coadministration on 5‐aminosalicylic acid oral suspension bioavailability , 1990, Clinical pharmacology and therapeutics.

[82]  T. Gramatté,et al.  Paracetamol absorption from different sites in the human small intestine. , 1994, British journal of clinical pharmacology.

[83]  R. Nayak,et al.  Effects of Meals and Meal Composition on the Bioavailability of Fenretinide , 1992, Journal of clinical pharmacology.

[84]  J. Sotelo,et al.  Pharmacokinetic study of praziquantel administered alone and in combination with cimetidine in a single-day therapeutic regimen , 1997, Antimicrobial agents and chemotherapy.

[85]  D. Fleisher,et al.  Nutrient effects on intestinal drug absorption. , 1990 .

[86]  G. Amidon,et al.  Effect of size and density on canine gastric emptying of nondigestible solids. , 1985, Gastroenterology.

[87]  J. Meddings,et al.  Review article: Intestinal permeability in Crohn's disease , 1997, Alimentary pharmacology & therapeutics.

[88]  O. Corrigan The biopharmaceutic drug classification and drugs administered in extended release (ER) formulations. , 1997, Advances in experimental medicine and biology.

[89]  P. Sinko,et al.  Site-specific oral absorption of didanosine: in situ characterization and correlation with extent of absorption in vivo , 1994 .

[90]  R. Neubert,et al.  Interactions between food components and drugs. Part 4: Influence of pectins and bile salts on propranolol absorption , 1996 .

[91]  P. Watkins Drug metabolism by cytochromes P450 in the liver and small bowel. , 1992, Gastroenterology clinics of North America.

[92]  D. Rowbotham,et al.  Cisapride. Drug interactions of clinical significance. , 1996, Drug safety.

[93]  S. Piscitelli,et al.  Protease inhibitors for the treatment of human immunodeficiency virus infection. , 1998, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[94]  R. Weintraub,et al.  Drug Interactions with Grapefruit Juice , 1997, Clinical pharmacokinetics.

[95]  P. Welling THE EFFECTS OF FOOD ON DRUG ABSORPTION , 1996, Annual review of nutrition.

[96]  F. Guengerich,et al.  Role of cytochrome P450 enzymes in drug-drug interactions. , 1997, Advances in pharmacology.

[97]  T. Browne,et al.  Sensitivity Analysis of the Effect of Bioavailability or Dosage Form Content on Mean Steady State Phenytoin Concentration , 1991, Therapeutic Drug Monitoring.

[98]  G. Amidon,et al.  Physicochemical model for dose-dependent drug absorption. , 1984, Journal of pharmaceutical sciences.

[99]  M. Härkönen,et al.  Gastric morphology, function, and immunology in first-degree relatives of probands with pernicious anemia and controls. , 1979, Scandinavian journal of gastroenterology.

[100]  M. Rogge,et al.  Effect of Food and a Monoglyceride Emulsion Formulation on Danazol Bioavailability , 1993, Journal of clinical pharmacology.

[101]  R. Mäntylä,et al.  Impairment of captopril bioavailability by concomitant food and antacid intake. , 1984, International journal of clinical pharmacology, therapy, and toxicology.

[102]  K. Pittman,et al.  Food‐induced reduction in bioavailability of didanosine , 1991, Clinical pharmacology and therapeutics.

[103]  D. Fleisher,et al.  Improved oral drug delivery: solubility limitations overcome by the use of prodrugs , 1996 .

[104]  H. Blackburn Olestra and the FDA. , 1996, The New England journal of medicine.

[105]  N. Carulli,et al.  Alcohol‐Drugs Interaction in Man: Alcohol and Tolbutamide * , 1971, European journal of clinical investigation.

[106]  A. Dietz,et al.  Ciprofloxacin Pharmacokinetics After a Standard or High‐Fat/High‐Calcium Breakfast , 1989, Journal of clinical pharmacology.

[107]  D. Fleisher,et al.  Colonic Absorption of Antiepileptic Agents , 1997, Epilepsia.

[108]  W. Kirch,et al.  Direct demonstration of small intestinal secretion and site‐dependent absorption of the β‐blocker talinolol in humans , 1996, Clinical pharmacology and therapeutics.

[109]  D. Fleisher,et al.  CCK antagonist pre-treatment inhibits meal-enhanced drug absorption in dogs , 1997, Regulatory Peptides.

[110]  M. Horowitz,et al.  Effects of increasing solid component size of a mixed solid/liquid meal on solid and liquid gastric emptying. , 1996, The American journal of physiology.

[111]  J. Dressman,et al.  Absorption of ACE inhibitors from small intestine and colon. , 1994, Journal of pharmaceutical sciences.

[112]  J. M. Shaw,et al.  Effect of Food on the Bioavailability of Captopril in Healthy Subjects , 1982, Journal of clinical pharmacology.

[113]  J. Dressman,et al.  Mixing-tank model for predicting dissolution rate control or oral absorption. , 1986, Journal of pharmaceutical sciences.

[114]  C. Beglinger,et al.  Relevance of p‐glycoprotein for the enteral absorption of cyclosporin A: in vitro‐in vivo correlation , 1996, British journal of pharmacology.

[115]  B. Gidal,et al.  Gabapentin Absorption: Effect of Mixing with Foods of Varying Macronutrient Composition , 1998, The Annals of pharmacotherapy.

[116]  T. Nadai,et al.  Effect of cyclodextrins on biological membrane. II. Mechanism of enhancement on the intestinal absorption of non-absorbable drug by cyclodextrins. , 1992, Chemical & pharmaceutical bulletin.

[117]  H. A. Koeleman,et al.  The influence of different types of breakfast on the absorption of paracetamol among members of an ethnic group. , 1992, International journal of clinical pharmacology, therapy, and toxicology.

[118]  Y. Seta,et al.  Design and preparation of captopril sustained-release dosage forms and their biopharmaceutical properties , 1988 .

[119]  S. Su,et al.  Inhibition of the intestinal digoxin absorption and exsorption by quinidine. , 1996, Drug Metabolism And Disposition.

[120]  Eric Woolf,et al.  Single-Dose Pharmacokinetics of Indinavir and the Effect of Food , 1998, Antimicrobial Agents and Chemotherapy.

[121]  J. N. Hunt Does calcium mediate slowing of gastric emptying by fat in humans? , 1983, The American journal of physiology.

[122]  G L Amidon,et al.  The influence of the interdigestive migrating myoelectric complex on the gastric emptying of liquids. , 1990, Gastroenterology.

[123]  P. D. Chao,et al.  Comparison of the Effects of Cimetidine and Ranitidine on the Pharmacokinetics of Disopyramide in Man , 1997, The Journal of pharmacy and pharmacology.

[124]  D. Greenblatt,et al.  Effect of Magnesium—Aluminum Hydroxide and Kaolin—Pectin on Absorption of Digoxin from Tablets and Capsules , 1981, Journal of clinical pharmacology.

[125]  D. Fleisher,et al.  Contrasting nutrient effects on the plasma levels of an amino acid-like antiepileptic agent from jejunal administration in dogs. , 1997, Journal of pharmaceutical sciences.

[126]  G. Bailie,et al.  Absorption Interactions With Fluoroquinolones , 1995, Drug safety.

[127]  M. Cavet,et al.  Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco‐2) cells , 1996, British journal of pharmacology.

[128]  U. Fuhr,et al.  Absorption differences of ciprofloxacin along the human gastrointestinal tract determined using a remote-control drug delivery device (HF-capsule). , 1989, The American journal of medicine.